English

MAIO, 26
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PERFIL DOS PARTICIPANTES

Categorias de produtos

Branded generics: 48.3%
96.6

Biological products: 43.3%
86.6

Biosimilars: 26.7%
53.4

Hospital products: 40.0%
80

Innovative medicines: 58.7%
117.4

mais informações




Interesses estratégicos

In-licensing: 46.7%
93.4

Out-licensing: 40.0%
80

Co-marketing: 31.7%
63.4

Co-promotion: 26.7%
53.4

Co-development: 46.7%
93.4

mais informações




Área terapêutica

Cardiovascular: 40.0%
80

CNS: 45.0%
90

Infectious diseases: 35.0%
70

Pain: 41.7%
83.4

Respiratory: 33.3%
66.6

mais informações



PARTICIPANTES 2016

In-licensing: 48.2%

Out-licensing: 46.4%

Co-marketing: 34.8%

Co-promotion: 28.6%

Co-development: 47.3%

Technology transfer: 17.9%

Outsourcing: 14.3%

Others: 16.1%

partner